Mantis Biotech integrates textbooks, motion-capture, biometric sensors, training logs, and medical imaging, routing and validating those inputs with LLM-based systems and a physics engine to produce high-fidelity synthetic datasets and digital twins. The platform creates physics-grounded, predictive models of anatomy, physiology, and behavior that can be used for performance prediction, testing procedures, training systems, and simulating edge cases or rare conditions where real data are scarce. The company has seen early commercial traction in professional sports, including work for an NBA team, and aims to target preventative healthcare as well as pharmaceutical researchers running FDA trials. Mantis plans to continue building its technology and eventually release the platform more broadly. The article does not disclose revenue, user counts, or a founding year.

Total raised

$7M

Funding rounds

1

Latest round

Seed

Latest activity

Mar 2026